SCHEMBL8560828

SCHEMBL8560828

[CH2]CCNC(=N)NC(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CA1 P00915 4/20 0.35
CA2 P00918 3/20 0.35
CA12 O43570 3/20 0.35
CA9 Q16790 2/20 0.35
EPHX1 P07099 1/20 0.35
CTSS P25774 4/20 0.33
CTSK P43235 4/20 0.33
CA7 P43166 2/20 0.33
IDO1 P14902 1/20 0.33
GLS O94925 1/20 0.32
NQO2 P16083 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA14 Q9ULX7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166624 0.81 TDP1 (0.58) TDP1MEN1GAAKMT2AMAOA
SCHEMBL16263827 0.80 TDP1 (0.41) TDP1MEN1GAAKMT2AMAOA
SCHEMBL8446923 0.80 TDP1 (0.46) TDP1MEN1GAAKMT2AMAOA
SCHEMBL604019 0.79 TDP1 (0.39) TDP1MEN1GAAKMT2ACA1
SCHEMBL8169567 0.78 TDP1 (0.37) TDP1MEN1GAAKMT2AMAOA
SCHEMBL349682 0.74 KDM4E (0.34)
Acetic Acid SCHEMBL3489390 0.74 MEN1 (0.38) TDP1MEN1GAAKMT2ACA1
SCHEMBL8233731 0.74 TDP1 (0.36) TDP1MEN1GAAKMT2ACA1
Guanidine SCHEMBL18128882 0.74 MAOA (0.39) TDP1MEN1GAAKMT2AMAOA
SCHEMBL30549392 0.73 MEN1 (0.55) TDP1MEN1GAAKMT2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed
WO-1996038426-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-05 WO disclosed